Quadrant Capital Group LLC Corcept Therapeutics Inc Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 2,712 shares of CORT stock, worth $181,487. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,712
Previous 2,042 32.81%
Holding current value
$181,487
Previous $66,000 89.39%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$29.51 - $46.26 $19,771 - $30,994
670 Added 32.81%
2,712 $125,000
Q2 2024

Aug 12, 2024
BUY
$22.21 - $34.48 $22 - $34
1 Added 0.05%
2,042 $66,000
Q1 2024

May 15, 2024
SELL
$21.1 - $27.46 $1,392 - $1,812
-66 Reduced 3.13%
2,041 $51,000
Q4 2023

Feb 08, 2024
BUY
$24.82 - $32.88 $11,119 - $14,730
448 Added 27.0%
2,107 $68,000
Q3 2023

Nov 14, 2023
BUY
$21.97 - $33.8 $7,623 - $11,728
347 Added 26.45%
1,659 $45,000
Q2 2023

Aug 09, 2023
BUY
$21.44 - $25.15 $2,208 - $2,590
103 Added 8.52%
1,312 $29,000
Q1 2023

May 11, 2023
SELL
$19.2 - $24.47 $4,396 - $5,603
-229 Reduced 15.92%
1,209 $26,000
Q4 2022

Feb 10, 2023
SELL
$19.95 - $29.96 $2,653 - $3,984
-133 Reduced 8.47%
1,438 $29,000
Q3 2022

Nov 10, 2022
BUY
$24.7 - $29.12 $34,036 - $40,127
1,378 Added 713.99%
1,571 $40,000
Q2 2022

Aug 09, 2022
SELL
$17.33 - $25.3 $1,282 - $1,872
-74 Reduced 27.72%
193 $5,000
Q1 2022

May 06, 2022
BUY
$16.53 - $25.21 $1,223 - $1,865
74 Added 38.34%
267 $6,000
Q4 2021

Feb 01, 2022
SELL
$17.1 - $23.34 $2,086 - $2,847
-122 Reduced 38.73%
193 $4,000
Q3 2021

Nov 12, 2021
BUY
$19.68 - $22.53 $2,302 - $2,636
117 Added 59.09%
315 $6,000
Q2 2021

Aug 09, 2021
SELL
$19.97 - $24.43 $459 - $561
-23 Reduced 10.41%
198 $4,000
Q1 2021

May 12, 2021
BUY
$23.49 - $30.56 $657 - $855
28 Added 14.51%
221 $5,000
Q2 2020

Aug 13, 2020
SELL
$11.0 - $18.26 $21,406 - $35,533
-1,946 Reduced 90.98%
193 $3,000
Q1 2020

May 15, 2020
BUY
$10.11 - $14.04 $596 - $828
59 Added 2.84%
2,139 $26,000
Q2 2019

Jul 24, 2019
BUY
$9.78 - $12.76 $19,442 - $25,366
1,988 Added 2160.87%
2,080 $23,000
Q1 2019

Apr 29, 2019
SELL
$10.03 - $15.71 $551 - $864
-55 Reduced 37.41%
92 $1,000
Q4 2018

Jan 17, 2019
BUY
$11.29 - $17.19 $620 - $945
55 Added 59.78%
147 $1,000
Q2 2018

Aug 09, 2018
SELL
$15.3 - $19.69 $2,218 - $2,855
-145 Reduced 61.18%
92 $1,000
Q1 2018

May 10, 2018
BUY
$14.59 - $25.5 $656 - $1,147
45 Added 23.44%
237 $3,000
Q2 2017

Aug 15, 2017
BUY
N/A
192
192 $2,000

Others Institutions Holding CORT

# of Institutions
355
Shares Held
86.2M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.17B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email